Home ETF List About

Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / FundiShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
IssuerBlackrock
Entity holding fund iShares VII Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF TickerCUS1(GBX) LSE
ETF TickerCUSS(USD) LSE
ETF TickerSXRG(EUR) F
ETF TickerCSUSS.MI(EUR) CXE
ETF TickerCSUSSz(USD) CXE
ETF TickerCUSS.LS(USD) CXE
ETF TickerCSUSS(EUR) ETF Plus
ETF TickerCUS1.L(GBP) LSE
ETF TickerCUSS.L(GBP) LSE

Holdings detail for WVE

Stock NameWave Life Sciences Ltd
TickerWVE(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINSG9999014716

Show aggregate WVE holdings

News associated with WVE

WAVE Life Sciences Ltd. (NASDAQ:WVE) Receives Average Rating of “Moderate Buy” from Analysts
WAVE Life Sciences Ltd. (NASDAQ:WVE – Get Free Report) has been assigned an average rating of “Moderate Buy” from the fifteen analysts that are covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold recommendation and fourteen have given a buy recommendation to the company. The average 1 year […] - 2025-09-19 03:14:54
Brokerages Set WAVE Life Sciences Ltd. (NASDAQ:WVE) PT at $20.27
WAVE Life Sciences Ltd. (NASDAQ:WVE – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the fifteen analysts that are covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold recommendation and fourteen have assigned a buy recommendation to the company. The average 12-month target price […] - 2025-08-28 03:14:50
WVE Crosses Above Key Moving Average Level
In trading on Monday, shares of Wave Life Sciences Ltd (Symbol: WVE) crossed above their 200 day moving average of $9.87, changing hands as high as $9.93 per share. Wave Life Sciences Ltd shares are currently trading up about 0.1% on the day. The chart below shows the one year - 2025-08-18 12:40:20
Chicago Partners Investment Group LLC Invests $103,000 in WAVE Life Sciences Ltd. (NASDAQ:WVE)
Chicago Partners Investment Group LLC purchased a new position in WAVE Life Sciences Ltd. (NASDAQ:WVE – Free Report) in the first quarter, according to its most recent disclosure with the SEC. The institutional investor purchased 12,708 shares of the company’s stock, valued at approximately $103,000. A number of other institutional investors also recently made changes […] - 2025-08-13 05:42:58
XTX Topco Ltd Makes New Investment in WAVE Life Sciences Ltd. (NASDAQ:WVE)
XTX Topco Ltd acquired a new position in WAVE Life Sciences Ltd. (NASDAQ:WVE – Free Report) in the first quarter, HoldingsChannel reports. The firm acquired 27,792 shares of the company’s stock, valued at approximately $225,000. A number of other hedge funds have also recently made changes to their positions in the business. Bank of New […] - 2025-08-13 04:26:46
WAVE Life Sciences (NASDAQ:WVE) Now Covered by Analysts at Canaccord Genuity Group
Canaccord Genuity Group initiated coverage on shares of WAVE Life Sciences (NASDAQ:WVE – Free Report) in a research note released on Monday morning, MarketBeat.com reports. The brokerage issued a buy rating and a $19.00 price objective on the stock. Several other research firms have also weighed in on WVE. Wedbush reiterated an “outperform” rating and […] - 2025-08-05 05:36:48
Wave (WVE) Q2 Revenue Drops 56%
Key PointsRevenue declined sharply to $8.7 million in Q2 fiscal year 2025, missing analyst expectations by 34.1% and falling 55.8% compared to the prior year period. - 2025-07-31 04:10:48
WAVE Life Sciences (NASDAQ:WVE) Coverage Initiated by Analysts at Citigroup
Equities research analysts at Citigroup started coverage on shares of WAVE Life Sciences (NASDAQ:WVE – Get Free Report) in a report released on Wednesday, Marketbeat.com reports. The firm set a “buy” rating and a $16.00 price target on the stock. Citigroup’s price target would indicate a potential upside of 99.75% from the company’s previous close. […] - 2025-07-18 05:05:15
WAVE Life Sciences (NASDAQ:WVE) Earns Outperform Rating from Wedbush
WAVE Life Sciences (NASDAQ:WVE – Get Free Report)‘s stock had its “outperform” rating reissued by research analysts at Wedbush in a note issued to investors on Monday,Benzinga reports. They presently have a $18.00 target price on the stock. Wedbush’s target price suggests a potential upside of 163.54% from the company’s previous close. Other research analysts […] - 2025-06-25 02:50:54
Wave Life Sciences (NASDAQ:WVE) Now Covered by Raymond James
Raymond James assumed coverage on shares of Wave Life Sciences (NASDAQ:WVE – Free Report) in a research report sent to investors on Wednesday morning, Marketbeat Ratings reports. The firm issued an outperform rating and a $14.00 target price on the stock. Several other equities research analysts have also issued reports on the stock. Jefferies Financial […] - 2025-06-12 04:56:56
Squarepoint Ops LLC Invests $256,000 in Wave Life Sciences Ltd. (NASDAQ:WVE)
Squarepoint Ops LLC purchased a new position in shares of Wave Life Sciences Ltd. (NASDAQ:WVE – Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 20,659 shares of the company’s stock, valued at approximately $256,000. Several other institutional investors have […] - 2025-06-08 06:38:59
Two Sigma Advisers LP Buys Shares of 68,100 Wave Life Sciences Ltd. (NASDAQ:WVE)
Two Sigma Advisers LP bought a new stake in Wave Life Sciences Ltd. (NASDAQ:WVE – Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund bought 68,100 shares of the company’s stock, valued at approximately $842,000. Other institutional investors and hedge […] - 2025-06-03 04:57:00
Universal Beteiligungs und Servicegesellschaft mbH Acquires Shares of 362,291 Wave Life Sciences Ltd. (NASDAQ:WVE)
Universal Beteiligungs und Servicegesellschaft mbH acquired a new stake in Wave Life Sciences Ltd. (NASDAQ:WVE – Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 362,291 shares of the company’s stock, valued at approximately $4,482,000. Universal Beteiligungs und Servicegesellschaft […] - 2025-06-02 05:57:07
Wave Life Sciences Ltd. (NASDAQ:WVE) Shares Sold by ProShare Advisors LLC
ProShare Advisors LLC reduced its holdings in Wave Life Sciences Ltd. (NASDAQ:WVE – Free Report) by 24.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 33,184 shares of the company’s stock after selling 10,820 shares during the period. ProShare […] - 2025-05-28 07:00:45
Wave Life Sciences Ltd. (NASDAQ:WVE) Shares Acquired by Two Sigma Investments LP
Two Sigma Investments LP grew its stake in Wave Life Sciences Ltd. (NASDAQ:WVE – Free Report) by 210.4% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 391,620 shares of the company’s stock after buying an additional 265,437 shares during the […] - 2025-05-28 05:04:55
Hsbc Holdings PLC Sells 3,565 Shares of Wave Life Sciences Ltd. (NASDAQ:WVE)
Hsbc Holdings PLC lessened its holdings in shares of Wave Life Sciences Ltd. (NASDAQ:WVE – Free Report) by 25.0% during the 4th quarter, Holdings Channel reports. The firm owned 10,721 shares of the company’s stock after selling 3,565 shares during the period. Hsbc Holdings PLC’s holdings in Wave Life Sciences were worth $132,000 at the […] - 2025-05-12 04:56:50
Voya Investment Management LLC Acquires 51,281 Shares of Wave Life Sciences Ltd. (NASDAQ:WVE)
Voya Investment Management LLC increased its holdings in shares of Wave Life Sciences Ltd. (NASDAQ:WVE – Free Report) by 198.2% during the fourth quarter, Holdings Channel.com reports. The firm owned 77,160 shares of the company’s stock after buying an additional 51,281 shares during the period. Voya Investment Management LLC’s holdings in Wave Life Sciences were […] - 2025-05-07 05:57:01
ESML's Holdings Could Mean 26% Gain Potential
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-05-06 08:37:29
MetLife Investment Management LLC Buys 12,340 Shares of Wave Life Sciences Ltd. (NASDAQ:WVE)
MetLife Investment Management LLC increased its stake in shares of Wave Life Sciences Ltd. (NASDAQ:WVE – Free Report) by 28.3% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 55,941 shares of the company’s stock after buying an additional 12,340 shares […] - 2025-05-05 05:22:48
Barclays PLC Has $2.42 Million Stake in Wave Life Sciences Ltd. (NASDAQ:WVE)
Barclays PLC increased its stake in shares of Wave Life Sciences Ltd. (NASDAQ:WVE – Free Report) by 22.8% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 195,553 shares of the company’s stock after buying an additional 36,312 shares during the quarter. Barclays PLC’s holdings in Wave Life Sciences were worth $2,418,000 at the […] - 2025-05-01 05:12:58
Wave Life Sciences (NASDAQ:WVE) Earns Overweight Rating from Analysts at Cantor Fitzgerald
Research analysts at Cantor Fitzgerald initiated coverage on shares of Wave Life Sciences (NASDAQ:WVE – Get Free Report) in a research note issued on Tuesday, Marketbeat Ratings reports. The firm set an “overweight” rating and a $10.00 price target on the stock. Cantor Fitzgerald’s price objective suggests a potential upside of 29.53% from the company’s […] - 2025-05-01 03:02:55
Tuesday's ETF Movers: IHE, BIZD
In trading on Tuesday, the iShares U.S. Pharmaceuticals ETF is outperforming other ETFs, up about 1.1% on the day. Components of that ETF showing particular strength include shares of Wave Life Sciences, up about 6% and shares of Pfizer, up about 3.6% on the day. And underperf - 2025-04-29 13:14:49
Russell Investments Group Ltd. Boosts Position in Wave Life Sciences Ltd. (NASDAQ:WVE)
Russell Investments Group Ltd. increased its holdings in Wave Life Sciences Ltd. (NASDAQ:WVE – Free Report) by 3,471.8% in the 4th quarter, HoldingsChannel reports. The fund owned 44,648 shares of the company’s stock after purchasing an additional 43,398 shares during the quarter. Russell Investments Group Ltd.’s holdings in Wave Life Sciences were worth $552,000 at […] - 2025-04-24 04:44:47
Wave Life Sciences (NASDAQ:WVE) Now Covered by Analysts at Wedbush
Analysts at Wedbush assumed coverage on shares of Wave Life Sciences (NASDAQ:WVE – Get Free Report) in a research note issued to investors on Tuesday, Marketbeat reports. The firm set an “outperform” rating and a $18.00 price target on the stock. Wedbush’s price objective would suggest a potential upside of 193.16% from the stock’s previous […] - 2025-04-10 04:13:09
Teacher Retirement System of Texas Grows Holdings in Wave Life Sciences Ltd. (NASDAQ:WVE)
Teacher Retirement System of Texas boosted its position in Wave Life Sciences Ltd. (NASDAQ:WVE – Free Report) by 57.6% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 31,473 shares of the company’s stock after acquiring an additional 11,507 shares during the quarter. Teacher Retirement System of Texas’ holdings in Wave Life Sciences were […] - 2025-04-01 04:44:43
Wave Life Sciences Ltd. (NASDAQ:WVE) Given Consensus Recommendation of “Buy” by Brokerages
Shares of Wave Life Sciences Ltd. (NASDAQ:WVE – Get Free Report) have been given a consensus rating of “Buy” by the ten analysts that are currently covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a hold recommendation, eight have issued a buy recommendation and one has issued a strong buy […] - 2025-03-28 04:08:55
Wave Life Sciences (NASDAQ:WVE) vs. Rhythm Pharmaceuticals (NASDAQ:RYTM) Financial Comparison
Wave Life Sciences (NASDAQ:WVE – Get Free Report) and Rhythm Pharmaceuticals (NASDAQ:RYTM – Get Free Report) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, risk, dividends, analyst recommendations, earnings and profitability. Analyst Recommendations This is a breakdown of […] - 2025-03-12 04:11:02
Wave Life Sciences (NASDAQ:WVE) Stock Rating Upgraded by StockNews.com
Wave Life Sciences (NASDAQ:WVE – Get Free Report) was upgraded by research analysts at StockNews.com from a “sell” rating to a “hold” rating in a research report issued on Saturday. Several other equities research analysts also recently issued reports on WVE. Jefferies Financial Group began coverage on shares of Wave Life Sciences in a research […] - 2025-03-10 04:20:52
Wave Life Sciences Ltd. (NASDAQ:WVE) Receives $22.60 Consensus PT from Brokerages
Shares of Wave Life Sciences Ltd. (NASDAQ:WVE – Get Free Report) have been given an average rating of “Buy” by the ten brokerages that are currently covering the stock, Marketbeat reports. One analyst has rated the stock with a hold rating, eight have issued a buy rating and one has issued a strong buy rating […] - 2025-03-06 04:45:53
Rhumbline Advisers Has $1.54 Million Holdings in Wave Life Sciences Ltd. (NASDAQ:WVE)
Rhumbline Advisers increased its position in shares of Wave Life Sciences Ltd. (NASDAQ:WVE – Free Report) by 16.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 124,840 shares of the company’s stock after purchasing an additional 17,316 shares during the quarter. Rhumbline […] - 2025-03-05 08:18:53

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc WVE holdings

DateNumber of WVE Shares HeldBase Market Value of WVE SharesLocal Market Value of WVE SharesChange in WVE Shares HeldChange in WVE Base ValueCurrent Price per WVE Share HeldPrevious Price per WVE Share Held
2025-09-26 (Friday)53,633USD 364,704USD 364,704
2025-09-25 (Thursday)53,633USD 357,196WVE holding decreased by -3754USD 357,1960USD -3,754 USD 6.66 USD 6.73
2025-09-24 (Wednesday)53,633USD 360,950USD 360,950
2025-09-17 (Wednesday)53,285USD 362,338WVE holding decreased by -1066USD 362,3380USD -1,066 USD 6.8 USD 6.82001
2025-09-16 (Tuesday)53,285USD 363,404USD 363,404
2025-09-12 (Friday)52,937USD 368,971USD 368,971
2025-09-11 (Thursday)52,937USD 379,029USD 379,029
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of WVE by Blackrock for IE00B3VWM098

Show aggregate share trades of WVE

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-08-21SELL-209 9.760* 9.56 Profit of 1,998 on sale
2025-07-31BUY624 8.100* 9.57
2025-06-30SELL-416 6.500* 9.83 Profit of 4,088 on sale
2025-06-25SELL-208 6.850* 9.89 Profit of 2,057 on sale
2025-06-20SELL-416 6.570* 9.96 Profit of 4,142 on sale
2025-05-23BUY208 5.950* 10.51
2025-05-19SELL-208 6.460* 10.66 Profit of 2,217 on sale
2025-05-15SELL-627 6.300* 10.73 Profit of 6,730 on sale
2025-05-12SELL-209 6.600* 10.85 Profit of 2,268 on sale
2025-05-09SELL-209 6.585* 10.89 Profit of 2,276 on sale
2025-04-30SELL-209 7.720* 11.13 Profit of 2,327 on sale
2025-04-24SELL-418 6.790* 11.30 Profit of 4,725 on sale
2025-04-17SELL-209 5.920* 11.57 Profit of 2,419 on sale
2025-04-15SELL-627 6.280* 11.69 Profit of 7,331 on sale
2025-04-14SELL-627 6.000* 11.76 Profit of 7,370 on sale
2025-04-09SELL-836 6.140* 11.96 Profit of 9,998 on sale
2025-04-07SELL-1,463 5.800* 12.11 Profit of 17,710 on sale
2025-04-04SELL-2,090 6.030* 12.18 Profit of 25,449 on sale
2025-03-31BUY209 8.080* 12.34
2025-03-19SELL-418 10.040* 12.64 Profit of 5,282 on sale
2025-03-14SELL-1,254 10.220* 12.75 Profit of 15,984 on sale
2025-03-13SELL-420 10.270* 12.78 Profit of 5,368 on sale
2025-03-12SELL-7,140 10.810* 12.81 Profit of 91,464 on sale
2025-03-07SELL-420 9.400* 12.95 Profit of 5,439 on sale
2025-03-06SELL-630 10.180* 12.99 Profit of 8,185 on sale
2025-03-03SELL-210 10.050* 13.11 Profit of 2,753 on sale
2025-02-28SELL-1,260 10.570* 13.15 Profit of 16,568 on sale
2025-02-26SELL-210 10.600* 13.24 Profit of 2,780 on sale
2025-02-25SELL-630 10.360* 13.29 Profit of 8,370 on sale
2025-02-18BUY1,050 11.030* 13.50
2025-02-13BUY210 10.800* 13.66
2025-02-12BUY210 10.910* 13.72
2025-02-11BUY630 10.410* 13.79
2025-02-06BUY1,890 11.840* 13.96
2025-01-27BUY210 12.200* 14.39
2024-12-30BUY1,050 12.410* 14.63
2024-12-06BUY840 15.270* 14.58
2024-12-05BUY210 14.440* 14.59
2024-12-04BUY1,045 14.500* 14.59
2024-11-29BUY1,045 15.100* 14.57
2024-11-27BUY836 14.990* 14.53
2024-11-26BUY209 14.830* 14.52
2024-11-25BUY7,955 14.890* 14.50
2024-11-21BUY925 14.350* 14.52
2024-11-20BUY555 14.260* 14.53
2024-11-18BUY2,220 12.850* 14.66
2024-11-12BUY1,472 15.890* 14.58
2024-11-08BUY920 16.440* 14.44
2024-11-07BUY2,760 14.830* 14.41
2024-11-06BUY368 14.200* 14.43
2024-10-31BUY184 13.710* 14.75
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of WVE

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19190,6960467,69340.8%
2025-09-18227,5900743,94730.6%
2025-09-17164,7390567,03829.1%
2025-09-16270,8510650,63741.6%
2025-09-15247,73040482,03851.4%
2025-09-12310,9973,190869,86335.8%
2025-09-11347,6901,3221,029,47133.8%
2025-09-10404,8030902,85044.8%
2025-09-09233,9940569,83541.1%
2025-09-08654,6600932,63170.2%
2025-09-05399,80701,235,66032.4%
2025-09-04571,68719,3651,405,33140.7%
2025-09-032,548,569134,3255,127,96249.7%
2025-09-02248,97923460,84054.0%
2025-08-29275,8202,205479,93657.5%
2025-08-28271,7370733,95137.0%
2025-08-27298,393150599,07049.8%
2025-08-26263,4910859,98030.6%
2025-08-25261,8620748,16435.0%
2025-08-22429,15038,154790,81854.3%
2025-08-21212,1840275,08977.1%
2025-08-20319,888573457,88569.9%
2025-08-19445,043575675,49965.9%
2025-08-18526,2910796,71466.1%
2025-08-15660,97915,8001,385,86847.7%
2025-08-14271,8132871,444,85218.8%
2025-08-13268,928829579,87346.4%
2025-08-12155,1750341,81545.4%
2025-08-11226,84501,355,12016.7%
2025-08-08216,3430394,46954.8%
2025-08-07292,2700469,14962.3%
2025-08-06509,78423,514846,79660.2%
2025-08-05408,9974,209544,82175.1%
2025-08-04537,4370758,26070.9%
2025-08-01413,08010,474606,13768.1%
2025-07-31396,0551,800558,11471.0%
2025-07-30363,4100593,46561.2%
2025-07-29457,0330762,58659.9%
2025-07-28321,058200576,27355.7%
2025-07-25205,508541397,70051.7%
2025-07-24191,2780347,43855.1%
2025-07-23358,2720556,04164.4%
2025-07-22196,3580367,35053.5%
2025-07-21403,86717,158697,01357.9%
2025-07-18569,9190940,38760.6%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.